NAUT
Nautilus Biotechnology, Inc. · Healthcare
AH Equity Partners Bio II, L.L.C. sold $11.8M of Nautilus Biotechnology, Inc.
10% owner
Sold$11,750,000
$2.35Price
5,000,000Shares
−84%Stake
What NAUT did after the filing
- The stock from Fri, Jun 5 open, $2.65
- −35.8%
- S&P 500, same days
- −0.5%
Measured over 30 trading days, to the Jul 21 close.
Traded Tue, Jun 2. Filed Thu, Jun 4, 4:53 PM ET, after the close. Returns use the Jun 5 open and the Jul 21 close. Not investment advice.